Carrick Therapeutics
Focus: Carrick Therapeutics is a publicly-listed Irish biotech focused on small molecule oncology and neurology programs. The company operates at a modest scale with a dispersed pipeline spanning early-stage cancer and neurological indications.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Carrick Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Carrick Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
23 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
NeuroCatch Platform
HealthyClinical Trials (1)
NCT03975023Investigating Event-Related Potentials and Eye-Tracking Measures in Hockey Players
N/AHelp build intelligence for Carrick Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.